Zerion Pharma A/S — Credit Rating and Financial Key Figures

Zerion Pharma A/S (CVR number: 40169229) is a company from KØBENHAVN. The company reported a net sales of 3.6 mDKK in 2023, demonstrating a growth of 8.8 % compared to the previous year. The operating profit percentage was poor at -335.6 % (EBIT: -11.9 mDKK), while net earnings were -11.1 mDKK. The profitability of the company measured by Return on Assets (ROA) was -53.6 %, which can be considered poor and Return on Equity (ROE) was -106.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -61.8 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Zerion Pharma A/S's liquidity measured by quick ratio was 2.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.